Therapeutic process for inhibiting NF-B

   
   

A therapeutic process is provided for the inhibition of NF-B in mammals in whose cells NF-B has been activated by an agency external to said cell.

 
Web www.patentalert.com

< - and -amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

< Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients

> Inhibitors for RNA viruses

> Methods for treating HIV-infected patients by the administration of GM-CSF and a protease inhibitor

~ 00197